Location: Home
  • search
  • go
  • Relate News
  • 1/12/2023Fosun Sees Surge in Demand from Mainland Chinese for Omicron-focused B...
  • 1/3/2023Legend Biotech's NDA for Ciltacabtagene Autoleucel (Cilta-Cel) Accepte...
  • 12/28/2022Everest Medicines Begins Operations at mRNA Vaccine Production Site in...
  • 12/27/2022Mainland Chinese May Now Get BioNTech COVID-19 Vaccines in Hong Kong...
  • 12/22/2022NHSA: Further Reduction of Drug and Medical Consumable Prices to Secur...
  • 12/21/2022BioNTech Sends First Batch of Vaccine to China for German Residents Th...
  • 12/19/2022Adagene Announces Clinical Trial Collaboration to Evaluate Anti-CTLA-4...
  • 12/13/2022China to Roll Out Second COVID Vaccine Booster for High-risk Groups, E...
  • 12/9/2022China Cracks Down on Drug Price Gouging amid Fears of COVID Spike: Reu...
  • 12/8/2022China's Reversal of Zero-Covid Policy to Boost Its Healthcare Sector: ...
  • 12/6/2022Summit and Akeso Reached ~$5B In-License Deal for Breakthru Innovative...
  • 11/30/2022NMPA Issues the List of Drugs Prohibited for Online Sales (Unofficial ...
  • 11/30/2022NMPA Issues the Announcement on Regulating the Filing and Reporting of...
  • 11/22/2022Measures for Supervision and Administration of Online Sales of Drugs: ...
  • 11/17/2022Marinus Pharma and Tenacia Biotech Tie Up for Ganaxolone Development ...
  • 11/15/2022WuXi Vaccines Buys Harbour BioMed China Facility
  • 11/14/2022BioNTech and Fosun Pharma Receive Special Approvals for Omicron-BA.4/B...
  • 11/11/2022NMPA Announces Package Insert Revision of Phloroglucinol Injection
  • 11/6/2022China to Approve BioNTech's Covid-19 Vaccine for Foreigners with Pathw...
  • 11/4/2022China Clarifies Regulations for Online Prescription Drug Sales, But Th...
  • 11/3/2022NMPA Releases the Draft List of Drugs Prohibited for Online Sales for ...
  • 10/26/2022CDE Solicits Comments on Draft Technical Guidelines for Clinical Trial...
  • 10/19/2022The Emergence of Commercial Health Insurances as An Access Route to th...
  • 10/12/2022Cracking the Code to Commercial Promise in Asia (PharmExec)
  • 10/9/2022CDE Solicits Comments on Draft Technical Guidelines for Clinical Trial...
  • 10/6/2022AIM Vaccine Launches IPO on the Main Board of SEHK
  • 10/6/2022Telemedicine Expanded to Rural China: Across the Divide
  • 10/4/2022Moderna Refuses Chinese Request to Hand Over mRNA Technology, Risking ...
  • 9/28/2022Qiming Venture: 'Overinvested' China Healthcare Sector Set for Shake U...
  • 9/27/2022Legend's Carvykti Wins Japanese Approval for Relapsed or Refractory M...
  • Page:13/77 Total number of articles:2286: [First][<<] [11] [12] [13] [14] [15] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group